Pharmaceutical nanotechnology for oral delivery of anticancer drugs

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200

New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?

Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815

Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers

Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623

Barrier properties of mucus

Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459

Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs

Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452

Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers

Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

Miwa, M., Ura, M., Nishida, M., Sawada, N., Ishikawa, T., Mori, K., Shimma, N., Umeda, I., & Ishitsuka, H. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00058-6 · Cited by 1,240

Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size

Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941

Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency

Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920

Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies

Pouton, C. W., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 885

Enhancing intestinal drug solubilisation using lipid-based delivery systems

Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690

Capecitabine: A review

Walko, C. M., & Lindley, C. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.005 · Cited by 659

Pharmacological Effects of Formulation Vehicles: Implications for Cancer Chemotherapy

ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00005 · Cited by 591

Vitamin E TPGS as a molecular biomaterial for drug delivery

Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586

Challenges for the oral delivery of macromolecules

Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544

Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update

Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442

Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)

Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 426

Lipid – An emerging platform for oral delivery of drugs with poor bioavailability

Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411

Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting

Frey, A., Giannasca, K. T., Weltzin, R., Giannasca, P. J., Reggio, H., Lencer, W. I., & Neutra, M. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1045 · Cited by 401

Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs

Dong, Y., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.021 · Cited by 395

Polymeric micelles for oral drug delivery

Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., & Leroux, J.-C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.007 · Cited by 389

Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases

Feng, S.-S., & Chien, S. (2003) · Chemical Engineering Science · doi:10.1016/s0009-2509(03)00234-3 · Cited by 364

Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailability

Gao, P., Rush, B. D., Pfund, W. P., Huang, T., Bauer, J. M., Morozowich, W., Kuo, M., & Hageman, M. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10511 · Cited by 361

Biopharmaceutical Parameters to Consider in Order to Alter The Fate of Nanocarriers After Oral Delivery

Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324

Fate of polymeric nanocarriers for oral drug delivery

Plapied, L., Duhem, N., des Rieux, A., & Préat, V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320

Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel

Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311

Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

Feng, S.-S., Mei, L., Anitha, P., Gan, C. W., & Zhou, W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.045 · Cited by 306

Oral chemotherapy: rationale and future directions.

DeMario, M. D., & Ratain, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2557 · Cited by 293

Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery

Benet, L. Z., Izumi, T., Zhang, Y., Silverman, J. A., & Wacher, V. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00034-6 · Cited by 292

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors

Grant, C., Rahman, F., Piekarz, R., Peer, C., Frye, R., Robey, R. W., Gardner, E. R., Figg, W. D., & Bates, S. E. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.88 · Cited by 291

Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs

Constantinou, C., Papas, A., & Constantinou, A. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23689 · Cited by 281

Multifunctional poly(D,L-lactide-co-glycolide)/ montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer

Sun, B., Ranganathan, B., & Feng, S.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.038 · Cited by 274

Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules

Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274

Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation

Nazzal, S., Smalyukh, I. I., Lavrentovich, O. D., & Khan, M. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00003-0 · Cited by 272

The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability

D'Emanuele, A., Jevprasesphant, R., Penny, J., & Attwood, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.006 · Cited by 269

Oral cancer treatment: developments in chemotherapy and beyond

O'Neill, V. J., & Twelves, C. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600591 · Cited by 269

Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant

Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265

The effect of physical barriers and properties on the oral absorption of particulates

Norris, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00037-4 · Cited by 262

Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus

Yang, M., Lai, S. K., Wang, Y., Zhong, W., Happe, C., Zhang, M., Fu, J., & Hanes, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006849 · Cited by 260

Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics

ALLEMANN, E. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00039-8 · Cited by 257

Recent Trends in Targeted Anticancer Prodrug and Conjugate Design

Singh, Y., Palombo, M., & Sinko, P. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132997 · Cited by 242

Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy

Bansal, T., Jaggi, M., Khar, R., & Talegaonkar, S. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3rc77 · Cited by 238

Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System?

Wiwattanapatapee, R., Carreño-Gómez, B., Malik, N., & Duncan, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007587523543 · Cited by 234

Relationships between the hydrophilic–lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines

Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233

Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing Its Solubility and Permeability1

Yu, L., Bridgers, A., Polli, J., Vickers, A., Long, S., Roy, A., Winnike, R., & Coffin, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018939006780 · Cited by 225

Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine

Singh, K. K., & Vingkar, S. K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.035 · Cited by 215

A folate receptor-targeted liposomal formulation for paclitaxel

Wu, J., Liu, Q., & Lee, R. J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.027 · Cited by 212

Nuclear delivery of macromolecules: barriers and carriers

BELTING, M., SANDGREN, S., & WITTRUP, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.004 · Cited by 209

Hydrotropic Polymeric Micelles for Enhanced Paclitaxel Solubility: In Vitro and In Vivo Characterization

Lee, S. C., Huh, K. M., Lee, J., Cho, Y. W., Galinsky, R. E., & Park, K. (2007) · Biomacromolecules · doi:10.1021/bm060307b · Cited by 206

Nanoparticles of biodegradable polymers for new-concept chemotherapy

Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206

Dendrimer Pharmacokinetics: The Effect of Size, Structure and Surface Characteristics on ADME Properties

Kaminskas, L. M., Boyd, B. J., & Porter, C. J. (2011) · Nanomedicine · doi:10.2217/nnm.11.67 · Cited by 204

Evaluation of nano- and microparticle uptake by the gastrointestinal tract

Delie, F. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00041-6 · Cited by 202

Coadministration of Cyclosporine Strongly Enhances the Oral Bioavailability of Docetaxel

Malingré, M. M., Richel, D. J., Beijnen, J. H., Rosing, H., Koopman, F. J., Ten Bokkel Huinink, W. W., Schot, M. E., & Schellens, J. H. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1160 · Cited by 199

The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles

Mo, R., Jin, X., Li, N., Ju, C., Sun, M., Zhang, C., & Ping, Q. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.005 · Cited by 198

In vitro evaluation of dendrimer prodrugs for oral drug delivery

Najlah, M., Freeman, S., Attwood, D., & D’Emanuele, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.047 · Cited by 195

Rapid Transport of Muco-Inert Nanoparticles in Cystic Fibrosis Sputum Treated with N -Acetyl Cysteine

Suk, J. S., Lai, S. K., Boylan, N. J., Dawson, M. R., Boyle, M. P., & Hanes, J. (2011) · Nanomedicine · doi:10.2217/nnm.10.123 · Cited by 185

Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells

Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9415-0 · Cited by 182

The mucosal immune system at the gastrointestinal barrier

Schenk, M., & Mueller, C. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.11.002 · Cited by 181

Characterization and Optimization of AMG 517 Supersaturatable Self‐Emulsifying Drug Delivery System (S‐SEDDS) for Improved Oral Absorption

Gao, P., Akrami, A., Alvarez, F., Hu, J., Li, L., Ma, C., & Surapaneni, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21451 · Cited by 166

Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol

YOUK, H., LEE, E., CHOI, M., LEE, Y., CHUNG, J., KIM, S., LEE, C., & LIM, S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.014 · Cited by 165

Enhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery System

Ke, W., Zhao, Y., Huang, R., Jiang, C., & Pei, Y. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21155 · Cited by 165

Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation

Bansal, T., Akhtar, N., Jaggi, M., Khar, R. K., & Talegaonkar, S. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.010 · Cited by 161

Oral Delivery of Taxanes

Malingré, M. M., Beijnen, J. H., & Schellens, J. H. M. (2001) · Investigational New Drugs · doi:10.1023/a:1010635000879 · Cited by 158

Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles

Agüeros, M., Zabaleta, V., Espuelas, S., Campanero, M. A., & Irache, J. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.012 · Cited by 156

Transport of dendrimer nanocarriers through epithelial cells via the transcellular route

Jevprasesphant, R., Penny, J. I., Attwood, D., & D’Emanuele, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.022 · Cited by 156

Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting

Li, F., Maag, H., & Alfredson, T. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21047 · Cited by 155

Microfabrication technologies for oral drug delivery

Sant, S., Tao, S. L., Fisher, O. Z., Xu, Q., Peppas, N. A., & Khademhosseini, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.013 · Cited by 149

SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer

Novotny‐Diermayr, V., Sangthongpitag, K., Hu, C. Y., Wu, X., Sausgruber, N., Yeo, P., Greicius, G., Pettersson, S., Liang, A. L., Loh, Y. K., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0689 · Cited by 141

Vitamin E Analogs, a Novel Group of “Mitocans,” as Anticancer Agents: The Importance of Being Redox-Silent

Neužil, J., Tomasetti, M., Zhao, Y., Dong, L., Birringer, M., Wang, X., Low, P., Wu, K., Salvatore, B. A., & Ralph, S. J. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030122 · Cited by 139

HDAC inhibitor-based therapies and haematological malignancy

Stimson, L., Wood, V. H. J., Khan, O. A., Fotheringham, S. A., & Thangue, N. B. L. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn792 · Cited by 136

Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.

Bardelmeijer, H. A., Ouwehand, M., Buckle, T., Huisman, M. T., Schellens, J. H. M., Beijnen, J. H., & van Tellingen, O. (2002) · PubMed · Cited by 135

Targeting the lymphatics using dendritic polymers (dendrimers)

Kaminskas, L. M., & Porter, C. J. H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.016 · Cited by 133

Co-administration of cyclosporin enables oral therapy with paclitaxel

Terwogt, J. M. M., Beijnen, J. H., Huinink, W. W. T. B., Rosing, H., & Schellens, J. H. M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)24030-x · Cited by 129

Histone deacetylases and epigenetic therapies of hematological malignancies

Mercurio, C., Minucci, S., & Pelicci, P. G. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.02.010 · Cited by 126

Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties

Arbós, P. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00066-x · Cited by 125

The effects of pharmaceutical excipients on drug disposition

Buggins, T. R., Dickinson, P. A., & Taylor, G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.017 · Cited by 125

Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study

Zabaleta, V., Ponchel, G., Salman, H. H., Agüeros, M., Vauthier, C., & Irache, J. M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.001 · Cited by 123

Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs

Rao, S. V. R., Yajurvedi, K., & Shao, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.015 · Cited by 122

Nanocarriers: A General Strategy for Enhancement of Oral Bioavailability of Poorly Absorbed or Pre-Systemically Metabolized Drugs

Cai, Z., Wang, Y., Zhu, L., & Liu, Z. (2010) · Current Drug Metabolism · doi:10.2174/138920010791110836 · Cited by 120

In Vitro and In Vivo Investigation on PLA–TPGS Nanoparticles for Controlled and Sustained Small Molecule Chemotherapy

Zhang, Z., Lee, S. H., Gan, C. W., & Feng, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9611-6 · Cited by 117

Localization and quantification of biodegradable particles in an intestinal cell model: The influence of particle size

Gaumet, M., Gurny, R., & Delie, F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.015 · Cited by 115

Enhanced Oral Bioavailability of Paclitaxel Formulated in Vitamin E-TPGS Emulsified Nanoparticles of Biodegradable Polymers: In Vitro and In Vivo Studies

Zhao, L., & Feng, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22113 · Cited by 109

Intestinal uptake and biodistribution of novel polymeric micelles after oral administration

Mathot, F., van Beijsterveldt, L., Véronique Préat, A., Brewster, M. E., & Ariën, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.012 · Cited by 101

Chemotherapeutic engineering: Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo

Feng, S., Zhao, L., Zhang, Z., Bhakta, G., Win, K. Y., Dong, Y., & Chien, S. (2007) · Chemical Engineering Science · doi:10.1016/j.ces.2007.08.006 · Cited by 98

Phase I and Pharmacokinetic Study of Oral Paclitaxel

Malingré, M. M., Terwogt, J. M. M., Beijnen, J. H., Rosing, H., Koopman, F. J., van Tellingen, O., Duchin, K., Huinink, W. W. T. B., Swart, M., Lieverst, J. A., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2468 · Cited by 96

Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile

Wang, H., Yu, N., Chen, D., Lee, K. C. L., Lye, P. L., Chang, J. W. W., Deng, W., Ng, M., Lu, T., Khoo, M. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2003552 · Cited by 94

Contribution of P-glycoprotein to the Enhancing Effects of Dimethyl-β-cyclodextrin on Oral Bioavailability of Tacrolimus

Arima, H., Yunomae, K., Hirayama, F., & Uekama, K. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)41709-6 · Cited by 90

Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.

Arima, H., Yunomae, K., Hirayama, F., et al. (2001) · PubMed · Cited by 85

Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier

Mathot, F., Rieux, A. D., Ariën, A., Schneider, Y., Brewster, M. E., & Véronique Préat, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.001 · Cited by 84

Enhanced Oral Absorption of Paclitaxel in N-Deoxycholic Acid-N, O-Hydroxyethyl Chitosan Micellar System

Li, H., Huo, M., Zhou, J., Dai, Y., Deng, Y., Shi, X., & Mohammad, J. M. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22159 · Cited by 81

Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells

Roger, E., Lagarce, F., Garcion, E., & Benoît, J. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.04.015 · Cited by 73

Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines

Arbós, P., Campanero, M. Á., Arangoa, M. A., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.006 · Cited by 67

Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer

Shen, Q., Wang, Y., & Zhang, Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s20903 · Cited by 64

Nanomedicine: Enhancement of Chemotherapeutical Efficacy of Docetaxel by Using a Biodegradable Nanoparticle Formulation

Gan, C. W., Chien, S., & Feng, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920487 · Cited by 53

Nanomedicine for Oral Chemotherapy

Feng, S., Zhao, L., & Tang, J. (2011) · Nanomedicine · doi:10.2217/nnm.11.7 · Cited by 47

Enhanced gastrointestinal absorption of N3-O-toluyl-fluorouracil by cationic solid lipid nanoparticles

Liu, D., Liu, C., Zou, W., & Zhang, N. (2009) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9648-4 · Cited by 38

Gastrointestinal uptake of liposomes. II. In vivo studies

Chia-Ming, C., & Weiner, N. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90059-7 · Cited by 35

Interaction of Modified Cyclodextrins with Cytochrome P-450

Ishikawa, M., Yoshii, H., & Furuta, T. (2005) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.69.246 · Cited by 35

Chemotherapeutic Engineering: Concept, Feasibility, Safety and Prospect—A Tribute to Shu Chien’s 80th Birthday

Feng, S. (2011) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-011-0198-3 · Cited by 30

A Phase I Study of Liposomal Doxorubicin (Doxil) With Topotecan

Ryan, C. W., Fleming, G. F., Janisch, L. A., & Ratain, M. J. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200006000-00019 · Cited by 27

Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics

Jayaraman, R., Reddy, V. P., Pasha, M. K., Wang, H., Sangthongpitag, K., Yeo, P., Hu, C. Y., Wu, X., Liu, X., Goh, E. M. L., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041558 · Cited by 25

NANOMEDICINE: NANOPARTICLES OF BIODEGRADABLE POLYMERS FOR CANCER DIAGNOSIS AND TREATMENT

Feng, S. (2008) · COSMOS · doi:10.1142/s0219607708000378 · Cited by 8

New developments in liposomal drug delivery

Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600

Metal-organic frameworks for advanced drug delivery

He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 528

Micro and nanoscale technologies in oral drug delivery

Ahadian, S., Finbloom, J. A., Mofidfar, M., Diltemiz, S. E., Nasrollahi, F., Davoodi, E., Hosseini, V., Mylonaki, I., Sangabathuni, S., Montazerian, H., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.012 · Cited by 268

Potential of Chitosan and its derivatives for controlled drug release applications – A review

Safdar, R., Omar, A. A., Arunagiri, A., Regupathi, I., & Thanabalan, M. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.10.020 · Cited by 147

Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug

Mu, Y., Fu, Y., Li, J., Yu, X., Li, Y., Wang, Y., Wu, X., Zhang, K., Kong, M., Feng, C., et al. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.09.020 · Cited by 113